Glucagon-like peptide-1
US$ 25.92
gip vs glp-1 Science Behind GLP 1 and Glucagon Receptor Agonists for Obesity Research | News & Announcements The activity of GLP-1 and
Description
Key players such as Novo Nordisk (DK), Eli Lilly (US), and Sanofi (FR) are at the forefront, each employing distinct strategies to enhance their market positions
Diabetes 61: 364-371, 2012
doi: 10.1158/1078-0432.CCR-06-2965
Both are subject to how others perceive them
